financetom
Business
financetom
/
Business
/
Polyrizon Receives Nasdaq Delisting Notice
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Polyrizon Receives Nasdaq Delisting Notice
May 26, 2025 1:42 PM

05:00 PM EDT, 05/23/2025 (MT Newswires) -- Polyrizon ( PLRZ ) said Friday it received a delisting notice from Nasdaq.

Nasdaq's staff decided to delist the company's securities following a review of its public filings with the SEC.

The decision was based on the company's issuance of securities under a March 31 purchase agreement, specifically Series A warrants exercisable on an alternate cashless basis, which Nasdaq said raised public interest concerns due to substantial dilution of shareholders.

The company said it plans to request a hearing before the Nasdaq Hearings Panel.

Shares of Polyrizon ( PLRZ ) were down nearly 6% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Enbridge Announces Conversion Results for Series 13 Preferred Shares
Enbridge Announces Conversion Results for Series 13 Preferred Shares
May 26, 2025
07:15 AM EDT, 05/21/2025 (MT Newswires) -- Enbridge ( ENB ) overnight Tuesday said that none of its outstanding cumulative redeemable Series 13 preference shares will be converted into cumulative redeemable Series 14 preference shares. A company statement said that by the May 20 deadline, less than the 1 million Series 13 shares required to give effect to conversions into...
Tango Therapeutics Doses First Patient for Phase 1/2 Trial to Treat Brain Cancer
Tango Therapeutics Doses First Patient for Phase 1/2 Trial to Treat Brain Cancer
May 26, 2025
07:59 AM EDT, 05/21/2025 (MT Newswires) -- Tango Therapeutics ( TNGX ) said Wednesday that the first patient has been dosed in its phase 1/2 trial to treat patients with methylthioadenosine phosphorylase-deleted solid tumors, with a focus on glioblastoma. TNG456 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor, the company said. People with GBM currently have few treatment options and a five-year...
BRIEF-Shift4 Further Extends Previously Announced Tender Offer To Acquire Global Blue
BRIEF-Shift4 Further Extends Previously Announced Tender Offer To Acquire Global Blue
May 26, 2025
May 21 (Reuters) - Shift4 Payments Inc ( FOUR ): * SHIFT4 FURTHER EXTENDS PREVIOUSLY ANNOUNCED TENDER OFFER TO ACQUIRE GLOBAL BLUE Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved